Related Experiment Videos
Interfering with disease: opportunities and roadblocks to harnessing RNA interference
Judy Lieberman1, Erwei Song, Sang-Kyung Lee
1Center for Blood Research and Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA. lieberman@cbr.med.harvard.edu
Trends in Molecular Medicine
|September 18, 2003
Summary
RNA interference (RNAi) uses small interfering RNAs (siRNA) to silence gene expression by degrading mRNA. This mechanism shows therapeutic potential for treating infections, cancer, and neurodegenerative diseases.
Area of Science:
- Molecular Biology
- Genetics
- Biotechnology
Background:
- RNA interference (RNAi) is a natural process for gene silencing.
- Small interfering RNAs (siRNA) are key effectors in RNAi pathways.
- RNAi has demonstrated efficacy in cellular and animal models.
Purpose of the Study:
- To explore the therapeutic potential of RNA interference.
- To investigate the use of siRNA for treating diseases.
Main Methods:
- Utilizing RNA interference mechanisms.
- Employing small interfering RNAs (siRNA) or siRNA-expressing plasmids.
- Administering treatments intravenously in mouse models.
Main Results:
- RNAi effectively silences gene expression via mRNA degradation.
- Intravenous siRNA administration protected mice from hepatitis.
- RNAi demonstrated potential in controlling tumor growth in vitro.
Conclusions:
- RNAi represents a promising therapeutic strategy.
- Potential applications include treating viral infections, cancer, and neurodegenerative disorders.
- Further research into RNAi-based therapies is warranted.